中醫出海 | 固生堂收購寶中堂新加坡,邁出國際化第一步
近日,固生堂附屬公司固生堂香港有限公司與寶中堂新加坡的股東訂立股權轉讓框架協議,擬收購寶中堂新加坡的100%股權。此收購事項符合集團通過收購擴大線下醫療機構網絡的擴張戰略,新加坡作為公司揚帆“出海”的第一站,是推動中醫藥走出國門、走向世界邁出的戰略性一步,正式開啟中醫國際化的新徵程。
寶中堂新加坡,最初由新加坡保健服務集團與上海申康醫院發展中心共同合作投資創建,於2007年在新加坡中央醫院設立“寶中堂中醫藥中心”。
新加坡保健服務集團(簡稱:新保集團)是新加坡規模最大的公共醫療保健集團,旗下包含4家醫院、5家國立專科中心以及8家綜合診所。新加坡中央醫院隸屬於新保集團,是亞洲最大的JCI公立教學醫院,同時也是新加坡規模最大、歷史最長的公立醫院,集國立專科中心和綜合性醫院於一體。上海申康醫院發展中心則是上海市政府設立的國有非營利性事業法人,旗下管理26家市級醫院。寶中堂新加坡的原投資創建方在新加坡和中國經營公立醫院方面皆有卓越的成就。
公司本次收購寶中堂新加坡,遵循了國家對中醫藥現代化、國際化的戰略要求,也是踐行“給傳統中醫插上互聯網與人工智能的翅膀,飛向全球”這一公司使命的關鍵舉措。東南亞國家民眾對優質中醫服務的需求與日俱增,新加坡是東南亞的“橋頭堡”,有利於公司海外業務向周邊國家輻射。
根據規劃,未來公司將持續通過戰略性投資、收併購等方式引進高質量合作伙伴,在新加坡及其他境外區域開設門店,不斷滿足世界人民對中醫診療及健康服務的需求,“先醫後藥”把固生堂的模式向境外縱深延展,將高質量的中醫服務帶到世界各地。
本文來自:微信公眾號“固生堂投資者關係”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.